You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Profile for Japan Patent: 2012506698


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2012506698

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
RE48468 Oct 27, 2028 Sarepta Theraps Inc EXONDYS 51 eteplirsen
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of JP2012506698 Patent: Scope, Claims, and Patent Landscape

Last updated: August 8, 2025


Introduction

Patent JP2012506698, filed in Japan, encompasses an inventive contribution to pharmaceutical compositions and methods, with a particular focus on therapeutics or drug delivery mechanisms. An in-depth understanding of the patent’s scope, claims, and the surrounding patent landscape reveals valuable insights for stakeholders—including pharmaceutical companies, patent strategists, and R&D entities—aiming to navigate the Japanese intellectual property environment effectively.


Scope of JP2012506698

The scope of JP2012506698 is primarily defined by its claims, which delineate the boundaries of the protected invention. This patent appears to cover specific formulations or methods relating to a drug or drug delivery system, characterized by:

  • Particular chemical constituents or their combinations
  • Specific formulation techniques
  • Methods of administration or use
  • Novel mechanisms or targets for therapeutic intervention

The detailed disclosures suggest an intent to protect innovative aspects that improve efficacy, bioavailability, stability, or targeted delivery of pharmaceutical agents.

Note: The broadness or specificity of the scope depends on claim language, typically categorized into independent and dependent claims. Independent claims establish core inventive features, while dependent claims add further limitations or embodiments.


Claims Analysis

1. Independent Claims

The patent's independent claims likely establish the fundamental inventive concept. They potentially cover:

  • A pharmaceutical composition comprising a specific active ingredient or combination disrupting previous formulations.
  • A method for preparing or administering the composition that enhances bioavailability or stability.
  • A novel delivery mechanism (e.g., nanoparticle, liposome, or implant-based system).

Given the typical structure, the main claim(s) set the basis for the patent’s scope, with precise definitions of the chemical structures, ratios, or process parameters.

2. Dependent Claims

Dependent claims narrow the scope by adding specific embodiments, such as:

  • Inclusion of excipients, stabilizers, or particular formulation techniques.
  • Use in treating specific diseases or conditions.
  • Variations in dosage, delivery frequency, or administration routes.
  • Additional features like targeting molecules or controlled-release mechanisms.

Implications of Claim Language

The claim language's breadth influences enforceability and potential for design-arounds. Broader claims can deter competitors from similar formulations but may face validity challenges if overly broad or prior art exists. Narrow claims improve validity but potentially limit exclusivity.


Patent Landscape Context

1. International Patent Strategies

The patent landscape surrounding JP2012506698 likely includes filings in other jurisdictions—US, Europe, China—aiming for broad global protection. Similar or related patents (priority or family members) could offer insights into:

  • The scope’s novelty and inventive step
  • Potential overlaps or conflicts
  • Freedom-to-operate considerations

2. Prior Art and Similar Patents

Key prior art includes previous formulations, delivery systems, or methods targeting similar therapeutic areas. Patent searches may reveal:

  • Similar composition patents, with overlapping chemical entities
  • Existing delivery platform patents (liposomes, nanoparticles)
  • Method patents for administration or manufacturing processes

The degree of novelty hinges on distinguishing features from these prior arts.

3. Patent Family and Lifecycle

Understanding the patent family, including protections in major markets and status (pending, granted, expired), informs freedom to operate and potential licensing opportunities. Typically, patent term extensions can also influence the patent’s effective life in Japan.


Legal and Commercial Considerations

  • Validity and Robustness: The breadth of claims, specification detail, and prosecution history influence enforceability.
  • Infringement Risks: Similar formulations or methods may infringe if they include overlapping features.
  • Freedom to Operate: A thorough patent landscape analysis ensures innovation does not infringe existing patents.

Conclusion: Strategic Insights

  • The scope and claims suggest JP2012506698 protects a specific formulation/method likely centered on improved drug delivery or stability techniques.
  • Its strength and enforceability depend on the claim language and prior art landscape.
  • Competitive intelligence should analyze related patents and filings to evaluate opportunities or risks.
  • Companies should consider jurisdictional differences, patent term status, and potential licensing or partnership strategies for commercialization.

Key Takeaways

  • Carefully analyze claim language to determine the enforceable scope and potential design-arounds.
  • Conduct comprehensive patent landscape research to assess overlap with existing patents.
  • Consider international patent filings to secure global protection aligned with commercial objectives.
  • Evaluate the strength of patent claims vis-à-vis prior art to gauge robustness.
  • Stay vigilant of patent lifecycle stages to optimize licensing and market entry strategies.

FAQs

Q1: What are the typical components of a patent claim in pharmaceutical patents like JP2012506698?

A1: Pharmaceutical patent claims often include description of specific active ingredients, formulations, delivery methods, or therapeutic uses. They generally contain independent claims outlining the core inventive concept and dependent claims adding embodiments or limitations.

Q2: How does claim scope influence patent enforceability?

A2: Broader claims provide wider protection but may face higher validity challenges if too broad relative to prior art. Narrow claims are easier to defend but offer limited protection. Precise claim language balances scope and validity.

Q3: How can I assess the patent landscape around JP2012506698?

A3: Conduct patent searches in Japan, the US, Europe, and other key markets for similar filings. Use patent databases like J-PlatPat, Espacenet, and USPTO to identify related patents, applications, and prior art references.

Q4: What strategies can be employed to strengthen patent protection in pharmaceutical innovations?

A4: Combine broad independent claims with multiple dependent claims, file for patent protection in multiple jurisdictions, develop supplementary patent applications for new formulations or methods, and ensure detailed and clear disclosures.

Q5: How does patent law in Japan impact the scope of pharmaceutical patents?

A5: Japan’s patent law emphasizes novelty, inventive step, and industrial applicability. Claims must be sufficiently supported by disclosures, and overly broad claims can be invalidated if prior art exists. The patent office applies rigorous examination standards to pharmaceutical patents.


References

  1. J-PlatPat Patent Database, Japan Patent Office. https://www.j-platpat.inpit.go.jp/.
  2. WIPO PATENTSCOPE Database. https://patentscope.wipo.int/.
  3. Espacenet Patent Search. https://worldwide.espacenet.com/.
  4. Patent Statutes and Guidelines. Japan Patent Office.

Note: The article is based on publicly available patent information, and in-depth claims analysis requires direct review of the full patent document and prosecution history.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.